New arthritis drug enters human testing phase
NCT ID NCT06567470
Summary
This study is testing whether an experimental drug called CIT-013 can reduce disease activity in adults with moderately active rheumatoid arthritis. 88 participants will receive either the drug or a placebo injection every other week for 6 weeks, with regular clinic checkups to monitor their symptoms. Researchers want to see if CIT-013 safely reduces joint swelling and pain compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BE-02
NOT_YET_RECRUITINGAntwerp, Belgium
Contact
-
DE-01
NOT_YET_RECRUITINGMünchen, Germany
Contact
-
DE-02
RECRUITINGMünchen, Germany
Contact
-
DE-03
RECRUITINGRatingen, Germany
Contact
-
DE-04
RECRUITINGBamberg, Germany
Contact
-
DE-05
RECRUITINGBerlin, Germany
Contact
-
ES-01
NOT_YET_RECRUITINGSantander, Spain
Contact
-
ES-02
RECRUITINGA Coruña, Spain
Contact
-
ES-03
RECRUITINGSantiago de Compostela, Spain
Contact
-
ES-04
RECRUITINGBarcelona, Spain
Contact
-
ES-05
NOT_YET_RECRUITINGBarcelona, Spain
Contact
-
ES-06
RECRUITINGMadrid, Spain
Contact
-
NL-01
RECRUITINGRotterdam, Netherlands
Contact
-
NL-02
RECRUITINGAmsterdam, Netherlands
Contact
-
NL-03
NOT_YET_RECRUITINGNijmegen, Netherlands
Contact
-
NL-04
WITHDRAWNLeiden, Netherlands
-
NL-05
RECRUITINGLeeuwarden, Netherlands
Contact
-
PL-01
RECRUITINGBialystok, Poland
Contact
-
PL-02
RECRUITINGPoznan, Poland
Contact
-
PL-03
RECRUITINGLublin, Poland
Contact
-
PL-04
RECRUITINGWarsaw, Poland
Contact
-
PL-05
RECRUITINGTorun, Poland
Contact
-
PL-07
RECRUITINGKrakow, Poland
Contact
-
Site BE-01
RECRUITINGLeuven, Belgium
Contact
Conditions
Explore the condition pages connected to this study.